BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31451055)

  • 1. Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine.
    Hayashi T; Konishi I
    Cancer Invest; 2019; 37(9):427-431. PubMed ID: 31451055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precision Medicine Provided by National Health Insurance].
    Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Panel Discussion - Problems in the Cancer Genomic Medicine].
    Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer genomic medicine in Japan.
    Mano H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current Status and Future Direction of Cancer Genomic Medicine].
    Nishio K; Sakai K
    Gan To Kagaku Ryoho; 2019 Sep; 46(9):1357-1360. PubMed ID: 31530770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
    Maggi E; Montagna C
    Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tensions in ethics and policy created by National Precision Medicine Programs.
    Minari J; Brothers KB; Morrison M
    Hum Genomics; 2018 Apr; 12(1):22. PubMed ID: 29665847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current Status and Issues of Companion Diagnostics in Cancer Genomic Medicine].
    Kanai M
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):388-391. PubMed ID: 38644302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
    Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
    Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of Cancer Genomic Board and Preparation of Genomic Report].
    Nakamura K; Nishihara H
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1141-1148. PubMed ID: 32829344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status and problems confronted in delivering precision medicine in Japan and Europe.
    Bando H
    Curr Probl Cancer; 2017; 41(3):166-175. PubMed ID: 28391973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Challenges in Expert Panel].
    Yachida S
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):994-996. PubMed ID: 36156023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
    Tsongalis GJ; Coleman WB
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overview of Clinical Application of Whole Genome Analysis for Cancer].
    Fukada I
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):7-13. PubMed ID: 38247084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Additional Remarks on the Issue of Cancer Genomic Medicine-Focusing on Medical Insurance Issues].
    Nishihara H
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1011-1013. PubMed ID: 36156029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.